Yukihiro Haruyama

Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma

Akinobu Ohno, Kenji Yorita, Yukihiro Haruyama et al. · Liver International · 2014 · 49 citations

Medicine, Cancer Biology, Oncology +17

Hepatocyte Growth Factor Activator Inhibitor Type 1 Is a Suppressor of Intestinal Tumorigenesis

Shinri Hoshiko, Makiko Kawaguchi, Tsuyoshi Fukushima et al. · Cancer Research · 2013 · 48 citations · Full text

Medicine, Cancer Biology, Oncology +10

High preoperative levels of serum glypican‐3 containing <scp>N</scp>‐terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy

Yukihiro Haruyama, Kenji Yorita, Tetsuji Yamaguchi et al. · International Journal of Cancer · 2015 · 45 citations · Full text

Medicine, Cancer Biology, Oncology +17

Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model

Jingjia Ye, Makiko Kawaguchi, Yukihiro Haruyama et al. · Cancer Science · 2013 · 40 citations · Full text

Medicine, Cell Biology, Oncology +12

Ghrelin administration suppresses inflammation‐associated colorectal carcinogenesis in mice

Makiko Kawaguchi, Ai Kanemaru, Tsuyoshi Fukushima et al. · Cancer Science · 2015 · 31 citations · Full text

Medicine, Endocrinology, Oncology +11